F Dx Advisors, Inc. Sanofi Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

A detailed history of F Dx Advisors, Inc. transactions in Sanofi stock. As of the latest transaction made, F Dx Advisors, Inc. holds 5,385 shares of SNY stock, worth $247,117. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,385

Previous 5,367 0.34%

Holding current value

$247,117

Previous $260,000 19.23%

% of portfolio

0.08%

Previous 0.07%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$48.54 - $58.53 $873 - $1,053	18 Added 0.34%	5,385 $310,000
Q2 2024 Aug 02, 2024	SELL	$45.39 - $50.36 $178,881 - $198,468	-3,941 Reduced 42.34%	5,367 $260,000
Q1 2024 May 03, 2024	SELL	$45.75 - $52.48 $273,996 - $314,302	-5,989 Reduced 39.15%	9,308 $452,000
Q4 2023 Feb 12, 2024	SELL	$43.13 - $54.79 $173,123 - $219,927	-4,014 Reduced 20.79%	15,297 $761,000
Q3 2023 Nov 02, 2023	SELL	$50.95 - $55.2 $223,925 - $242,604	-4,395 Reduced 18.54%	19,311 $1.04 Million
Q2 2023 Jul 17, 2023	BUY	$50.45 - $57.18 $320,105 - $362,807	6,345 Added 36.55%	23,706 $1.28 Million
Q4 2022 Feb 09, 2023	SELL	$38.86 - $48.55 $20,129 - $25,148	-518 Reduced 2.9%	17,361 $841,000
Q3 2022 Nov 10, 2022	SELL	$37.22 - $100.5 $527,146 - $1.42 Million	-14,163 Reduced 44.2%	17,879 $680,000
Q2 2022 Aug 03, 2022	BUY	$48.99 - $57.46 $27,924 - $32,752	570 Added 1.81%	32,042 $1.6 Million
Q1 2022 May 03, 2022	BUY	$48.48 - $53.65 $112,425 - $124,414	2,319 Added 7.95%	31,472 $1.62 Million
Q4 2021 Feb 01, 2022	BUY	$47.07 - $52.35 $34,596 - $38,477	735 Added 2.59%	29,153 $1.46 Million
Q3 2021 Oct 08, 2021	BUY	$47.89 - $53.12 $123,125 - $136,571	2,571 Added 9.95%	28,418 $1.37 Million
Q2 2021 Aug 05, 2021	BUY	$49.36 - $54.25 $832,357 - $914,817	16,863 Added 187.7%	25,847 $1.36 Million
Q1 2021 Apr 14, 2021	BUY	$45.46 - $50.51 $388,228 - $431,355	8,540 Added 1923.42%	8,984 $444,000
Q1 2021 Apr 13, 2021	SELL	$45.46 - $50.51 $705,493 - $783,864	-15,519 Reduced 97.22%	444 $21,000
Q4 2020 Feb 08, 2021	SELL	$45.3 - $51.62 $2,265 - $2,581	-50 Reduced 0.31%	15,963 $776,000
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $35,816 - $38,929	-724 Reduced 4.33%	16,013 $803,000
Q2 2020 Jul 22, 2020	SELL	$42.91 - $52.5 $66,682 - $81,585	-1,554 Reduced 8.5%	16,737 $854,000
Q1 2020 May 22, 2020	BUY	$38.02 - $51.66 $160,444 - $218,005	4,220 Added 29.99%	18,291 $800,000
Q1 2020 May 13, 2020	BUY	$38.02 - $51.66 $127,975 - $173,887	3,366 Added 31.44%	14,071 $258,000
Q4 2019 Feb 12, 2020	BUY	$44.25 - $50.86 $103,368 - $118,808	2,336 Added 27.91%	10,705 $537,000
Q3 2019 Nov 07, 2019	SELL	$40.34 - $46.64 $841,815 - $973,283	-20,868 Reduced 71.38%	8,369 $388,000
Q2 2019 Jul 19, 2019	SELL	$40.43 - $44.3 $106,613 - $116,819	-2,637 Reduced 8.27%	29,237 $1.27 Million
Q1 2019 May 14, 2019	BUY	$40.83 - $45.43 $967,303 - $1.08 Million	23,691 Added 289.51%	31,874 $1.41 Million
Q4 2018 Apr 29, 2019	SELL	$41.48 - $45.59 $1.02 Million - $1.13 Million	-24,687 Reduced 75.1%	8,183 $355,000
Q4 2018 Feb 07, 2019	SELL	$41.48 - $45.59 $82,047 - $90,177	-1,978 Reduced 5.68%	32,870 $1.43 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $1.57 Million - $1.76 Million	-39,295 Reduced 53.0%	34,848 $1.56 Million
Q2 2018 Aug 08, 2018	SELL	$37.63 - $41.22 $1.41 Million - $1.55 Million	-37,555 Reduced 33.62%	74,143 $2.97 Million
Q1 2018 May 02, 2018	SELL	$38.98 - $45.76 $742,919 - $872,139	-19,059 Reduced 14.58%	111,698 $4.48 Million
Q4 2017 Feb 09, 2018	SELL	$42.86 - $50.61 $254,545 - $300,572	-5,939 Reduced 4.34%	130,757 $5.62 Million
Q3 2017 Nov 03, 2017	SELL	$47.04 - $50.34 $332,713 - $356,054	-7,073 Reduced 4.92%	136,696 $6.81 Million
Q2 2017 Aug 11, 2017	BUY	N/A	143,769	143,769 $6.89 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $115B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account